Samlyn Capital, LLC Merus N.V. Transaction History
Samlyn Capital, LLC
- $6.07 Billion
- Q1 2025
A detailed history of Samlyn Capital, LLC transactions in Merus N.V. stock. As of the latest transaction made, Samlyn Capital, LLC holds 2,379,428 shares of MRUS stock, worth $103 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
2,379,428
Previous 2,668,178
10.82%
Holding current value
$103 Million
Previous $112 Million
10.74%
% of portfolio
1.65%
Previous 1.81%
Shares
11 transactions
Others Institutions Holding MRUS
# of Institutions
198Shares Held
62.3MCall Options Held
355KPut Options Held
96.5K-
Octagon Capital Advisors LP New York, NY5.14MShares$223 Million22.37% of portfolio
-
Wellington Management Group LLP Boston, MA4.72MShares$205 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$194 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$181 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$146 Million7.27% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.99B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...